Showing results 1 - 10 of 17
At GJE our specialist and highly experienced biotech patent attorneys have a deep understanding of the commercial realities of the sector. We appreciate the strategic value of IP to a biotech company...
Director Lucy Samuels from our Chemistry and life sciences team will be moderating the panel discussion ‘’Claim interpretation, description conflicts, and the next chapter in life sciences after G...
GJE is pleased to announce that the firm has formed an alliance with the German patent and trade mark firm Wächtershäuser & Hartz (W&H)...
Thursday 14 March 2024 I 6:00 pm (London UK – GMT) GJE look forward to hosting the next Biotech Buddies networking event at our office in Broadgate Tower. Several members of our chemistry and life s...
On 21 March, Imago BioSciences, Inc., a clinical-stage biotechnology company developing innovative treatments for myeloid diseases, announced a $40 million Series B financing led by Omega Funds, a GJE...
Join us at the Bio Integrates conference on 14 May 2026 which will explore how biotech companies can thrive in an evolving landscape....
Ash Earl, a senior associate in our chemistry and life sciences team, will deliver the session on ‘’Intellectual Property Rights’’ as part of the course. ...
Ross Cummings a partner in our life sciences and biotech team will be hosting and moderating a panel at the AUTM Annual Meeting 2026....
In the latest article in our series, we outline the key considerations for innovators and applicants when patenting microbiome-related technologies in Europe....
In this article, we outline the key considerations for innovators and applicants when patenting PROTACs in Europe....